alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Official Journal L 167/2016

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 167 |
| | |
| English edition | Legislation | Volume 5924 June 2016 |

ISSN 1977-0677

Official Journal

of the European Union

L 167

English edition

Legislation

Volume 5924 June 2016

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Commission Regulation (EU) 2016/1002 of 17 June 2016 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for AMTT, diquat, dodine, glufosinate and tritosulfuron in or on certain products (
  1
  ) | 1 |
| | * | Commission Regulation (EU) 2016/1003 of 17 June 2016 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin, acequinocyl, acetamiprid, benzovindiflupyr, bromoxynil, fludioxonil, fluopicolide, fosetyl, mepiquat, proquinazid, propamocarb, prohexadione and tebuconazole in or on certain products (
  1
  ) | 46 |

Contents

II   Non-legislative acts

page

REGULATIONS

*

Commission Regulation (EU) 2016/1002 of 17 June 2016 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for AMTT, diquat, dodine, glufosinate and tritosulfuron in or on certain products (
  1
  )

1

1

*

Commission Regulation (EU) 2016/1003 of 17 June 2016 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin, acequinocyl, acetamiprid, benzovindiflupyr, bromoxynil, fludioxonil, fluopicolide, fosetyl, mepiquat, proquinazid, propamocarb, prohexadione and tebuconazole in or on certain products (
  1
  )

1

46

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
<PAGE>

                                                                     EXHIBIT 23


Report of Independent Accountants on Consolidated Financial Statement Schedules

     Our audit was made for the purpose of forming an opinion on the basic
financial statements taken as a whole. Schedule II included in Form 10-K is
presented for purposes of complying with the Securities and Exchange Commission
rules and is not part of the basic financial statements. This schedule has been
subjected to the auditing procedures applied in the audit of the basic financial
statements, and in our opinion, fairly states in all material respects the
financial data required to be set forth therein in relation to the basic
financial statements taken as a whole.
| 1. | In order to ensure that the company has sufficient working capital to execute its business plan, I hereby waive my right to receive any bonus payments as provided in the Bonus Payment Agreement dated October 7, 2010, for the Fiscal Year of First China Pharmaceutical Group, Inc. ending March 31, 2011. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | No amounts due for the Fiscal Year of First China Pharmaceutical Group, Inc. ending March 31, 2011 will be carried forward.  I absolve all interests in any payments due to me for the Fiscal Year of First China Pharmaceutical Group, Inc. ending March 31, 2011. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | By May 30, 2011, I will inform the Board of First China Pharmaceutical Group, Inc. of my intentions of bonus payments due to me, as provided in the Bonus Payment Agreement dated October 7, 2010, for all or part of the Fiscal Year of First China Pharmaceutical Group, Inc. ending March 31, 2012. |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/ Zhen Jiang Wang                         |   |
|---------------------------------------------|--------|
| Mr. Zhen Jiang Wang                         |   |
|          |   |
| /s/ Gregory D. Tse                          |   |
| Witness                                     |   |
**EXHIBIT 32.2**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report of Adelphia Recovery Trust (the “Trust”) on Form 10-Q for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jeffrey A. Brodsky, a member of Quest Turnaround Advisors, LLC, Trust Administrator of the Trust, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust.

 

 
| By:  Quest Turnaround Advisors,   LLC              |   |
|---------------------------------------------------------|--------|
| as   Trust Administrator of the Adelphia Recovery Trust |   |
|                                                    |   |
| /s/   Jeffrey A. Brodsky                                |   |
| Jeffrey   A. Brodsky                                    |   |
| Member                                                  |   |
|                                                    |   |
|                                                    |   |
| Date:   May 13, 2011                                    |   |

 

1

----
I 

115TH CONGRESS 

2D SESSION H. R. 5948 

To exempt motor carriers that own or operate 10 or fewer commercial vehicles 

from the electronic logging device mandates, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 23, 2018 

Mr. PETERSON (for himself, Mr. GIANFORTE, and Mr. KING of Iowa) introduced the following bill; which was referred to the Committee on Transportation and Infrastructure 

A BILL 

To exempt motor carriers that own or operate 10 or fewer 

commercial vehicles from the electronic logging device 

mandates, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Small Carrier Elec5 tronic Logging Device Exemption Act of 2018’’. 


dlhill on DSK3GLQ082PROD with BILLS
2 

•HR 5948 IH

1 SEC. 2. EXCEPTION TO THE ELECTRONIC LOGGING DEVICE 

2 REQUIREMENTS FOR MOTOR CARRIERS 

3 THAT OWN OR OPERATE 10 OR FEWER COM4 MERCIAL VEHICLES. 

5 Section 31137(b)(3) of title 49, United States Code, 

6 is amended to read as follows: 

7 ‘‘(3) EXCEPTION.— 

8 ‘‘(A) IN GENERAL.—An excepted motor 

9 carrier may comply with the hours of service re10 quirements by requiring each driver to use— 

11 ‘‘(i) a paper record of duty status 

12 form; or 

13 ‘‘(ii) an electronic logging device. 

14 ‘‘(B) EXCEPTED MOTOR CARRIER DE15 FINED.—In this subsection, the term ‘excepted 

16 motor carrier’ means— 

17 ‘‘(i) a motor carrier when transporting 

18 a motor home or recreation vehicle trailer 

19 within the definition of the term 

20 ‘driveaway-towaway operation’ (as defined 

21 in section 390.5 of title 49, Code of Fed22 eral Regulations); and 

23 ‘‘(ii) a motor carrier that owns or op24 erates 10 or fewer commercial motor vehi25 cles, including commercial motor vehicles 

26 owned or operated by all motor carriers afVerDate Sep 11 2014 00:30 Jun 02, 2018 Jkt 079200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H5948.IH H5948

dlhill on DSK3GLQ082PROD with BILLS
3 

•HR 5948 IH

1 filiated with that motor carrier by common 

2 ownership, common management, common 

3 control, or common familiar relationship.’’. 

4 SEC. 3. REQUIREMENT TO PRESCRIBE REGULATIONS. 

5 Not later than 90 days after the date of enactment 

6 of this Act, the Secretary of Transportation shall promul7 gate such regulations as are necessary to carry out the 

8 amendment made by section 2 of this Act. 

Æ 


dlhill on DSK3GLQ082PROD with BILLS
[CIC letterhead]


 


Exhibit 10.75


 


December 3, 2015


 


FirstGlobal Partners LLC

6000 E. Horseshoe Road

Paradise Valley AZ 85253

Attn.: William Keiper, Managing Partner


 


Re: Compensation Deferral


 


Dear Will


 


Reference is made to that certain Note Purchase Agreement, dated
as of November 25, 2015, by and among Communication Intelligence Corporation (the “Company”) and certain accredited
investors (the “Note Purchase Agreement”). All capitalized terms used herein that are not defined shall have
the meaning assigned to those terms in the Note Purchase Agreement.


 


This letter will serve to confirm that you have agreed to defer
compensation owed to you (and to be owed to you provided you continue to provide your services to the Company for the applicable
period), as set forth herein. In exchange for the deferral of your compensation as set forth on Exhibit A attached hereto
(the “Deferred Compensation”), the Company agrees that such Deferred Compensation will be an unsecured obligation
of the Company with the same terms and subject to the same provisions, mutatis mutandis, as those set forth in the Note.


 


For any Deferred Compensation owed as of September 30, 2015,
interest will accrue commencing on October 1, 2015. For any Deferred Compensation generated in any given month starting with October
2015, interest will begin to accrue beginning on the first day of the following month. For example, if $1,000 of Deferred Compensation
is generated in October 2015, interest will first begin to accrue on such amount starting November 1. No interest will accrue on
such amount during the month of October.


 


This letter shall be governed by, and construed in accordance
with, the laws of the State of New York excluding that body of law relating to conflicts of law.


 


[Remainder of page left blank intentionally]


 


 


 






    	 



    	 



    

 





Deferred Compensation Side Letter –
FGP





Page 2




 


Please indicate your agreement and acceptance of the terms and
conditions of this letter agreement by executing this letter agreement in the designated space below.


 


Very truly yours,


 


COMMUNICATION INTELLIGENCE CORPORATION


 


By:    /s/ Andrea Goren                                                

Name: Andrea Goren

Title: Chief Financial Officer


 


 


  


AGREED AND ACCEPTED:


 


FIRSTGLOBAL PARTNERS LLC


 


By:    /s/ William Keiper                                               

Name: William Keiper

Title: Managing Partner


 






    	 



    	 



    

 


EXHIBIT
A


 


Deferred
Compensation for FIRSTGLOBAL PARTNERS LLC


 


Estimated through March 31, 20161.


 


	Amount	Month	Year
	$10,000.00	July	2015
	$10,000.00	August	2015
	$10,000.00	September	2015
	$20,000.00	October	2015
	$20,000.00	November	2015
	$20,000.00	December	2015
	$20,000.00	January	2016
	$20,000.00	February	2016
	$20,000.00 	March	2016
	
        $150,000.00
	 	 



 


 


 


 


 


 







1
Actual Deferred Compensation will depend on timing of the Next Equity Financing.
Ernploynlent Standards Administration 

Office of Workers' Compensation Programs 

Division of Energy Employees Occupational 

Illness Compensat~on 

Washington, D.C. 20210 

P *7 -- .! ,< - i) ,-I 4 '1 ! 1 J I i- : 3 ,2 2 ( \,/ ;> 

Mr. Larry Elliott, Director 

Office of Compensation Analysis and Support 

National Institute for Occupational Safety and Health 

4676 Columbia Parkway, Mailstop C-46 

Cincinnati, OH 45226 

Dear Mr. Elliott: 

As part of recent discussions regarding Blockson Chemical, I agreed to provide 

comments to you regarding which portions of the facility are covered under the Energy 

Employees Occupational Illness Compensation Program Act (EEOICPA). In providing 

these comments, my staff and I have reviewed our documentation as well as the most 

recent Department of Energy Federal Register notice designating Blockson Chemical as 

an Atomic Weapons Employer (AWE). The current Federal Register notice, dated 

August 23,2004, designates "Blockson Chemical Co. (Building 55 and related activities) 

in Joliet, Illinois" as an AWE. Our determination is that this designation covers 

Building 55, the pilot plant and the associated processes (including the oxidation 

process) and all the areas in which these processes were performed. Thus, the National 

Institute for Occupational Safety and Health (NIOSH) will need to determine what 

radiation covered by EEOICPA was present in these areas and include such radiation in 

its dose reconstruction process. We would also re-affirm comments previously 

provided to NIOSH on the earlier versions of the Blockson Chemical Company 

Technical Basis Documents. 

If you have any questions i? regard to this matter, please fed frce tc cmtact 1-1c at 

(202)693-0081. 

Peter.M. Turcic 

Director, Division of Energy Employees 

Occupational lllness Compensation
Electronically Filed Supreme Court SCWC-16-0000005 18-JUL-2016 10:41 AM

SCWC-16-0000005 IN THE SUPREME COURT OF THE STATE OF HAWAI ' I
DWIGHT J. VICENTE, Petitioner/Claimant-Appellant,

vs. HILO MEDICAL INVESTORS, LTD., Respondent/Employer-Appellee, and JOHN MULLEN & COMPANY, INC., Respondent/Insurance Carrier-Appellee.

CERTIORARI TO THE INTERMEDIATE COURT OF APPEALS (CAAP-16-0000005; AB 2015-259(H); DCD NO. 1-87-00882)

ORDER REJECTING APPLICATION FOR WRIT OF CERTIORARI (By: Recktenwald, C.J., Nakayama, McKenna, Pollack, and Wilson, JJ.) The application for writ of certiorari, filed on June 13, 2016, is hereby rejected. DATED: Honolulu, Hawai ' i, July 18, 2016. Dwight J. Vicente, pro se /s/ Mark E. Recktenwald /s/ Paula A. Nakayama /s/ Sabrina S. McKenna /s/ Richard W. Pollack /s/ Michael D. Wilson
Exhibit 32.1




CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002




In connection with the annual report of Sino Green Land Corporation (the “Company”) on Form 10-Q for the quarter ended September 30, 2010, as filed with the Securities and Exchange Commission (the “Report”), Xiong Luo, chief executive officer of the Company, and Huasong Sheena Shen, chief financial officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:




1.
The Company’s Quarterly Report on Form 10-Q for the nine months ended September 30, 2010 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and




2.
Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.





November 15, 2010
/s/ Xiong LuoXiong LuoChief Executive Officer and President(Principal Executive Officer)





/s/ Huasong Sheena ShenNovember 15, 2010
Huasong Sheena ShenChief Financial Officer(Principal Financial and Accounting Officer)







A signed original of this written statement required by Section 906 has been provided to Sino Green Land Corporation and will be retained by Sino Green Land Corporation and furnished to the Securities and Exchange Commission or its staff upon request.




The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to §18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
# C_2011180EN.01001001.xml

| 21.6.2011 | EN | Official Journal of the European Union | C 180/10 |
| --- | --- | --- | --- |

21.6.2011

EN

Official Journal of the European Union

C 180/10

---

Euro exchange rates (1)

1

20 June 2011

2011/C 180/05

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,4235 |
| JPY | Japanese yen | 114,24 |
| DKK | Danish krone | 7,4594 |
| GBP | Pound sterling | 0,87950 |
| SEK | Swedish krona | 9,1708 |
| CHF | Swiss franc | 1,2039 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 7,9265 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,125 |
| HUF | Hungarian forint | 269,00 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7090 |
| PLN | Polish zloty | 3,9898 |
| RON | Romanian leu | 4,2710 |
| TRY | Turkish lira | 2,2940 |
| AUD | Australian dollar | 1,3528 |
| CAD | Canadian dollar | 1,4004 |
| HKD | Hong Kong dollar | 11,0946 |
| NZD | New Zealand dollar | 1,7662 |
| SGD | Singapore dollar | 1,7617 |
| KRW | South Korean won | 1 545,80 |
| ZAR | South African rand | 9,6628 |
| CNY | Chinese yuan renminbi | 9,2216 |
| HRK | Croatian kuna | 7,3850 |
| IDR | Indonesian rupiah | 12 267,45 |
| MYR | Malaysian ringgit | 4,3267 |
| PHP | Philippine peso | 62,193 |
| RUB | Russian rouble | 40,1025 |
| THB | Thai baht | 43,559 |
| BRL | Brazilian real | 2,2869 |
| MXN | Mexican peso | 16,9910 |
| INR | Indian rupee | 64,0680 |

Currency

Exchange rate

USD

US dollar

1,4235

JPY

Japanese yen

114,24

DKK

Danish krone

7,4594

GBP

Pound sterling

0,87950

SEK

Swedish krona

9,1708

CHF

Swiss franc

1,2039

ISK

Iceland króna

NOK

Norwegian krone

7,9265

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,125

HUF

Hungarian forint

269,00

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7090

PLN

Polish zloty

3,9898

RON

Romanian leu

4,2710

TRY

Turkish lira

2,2940

AUD

Australian dollar

1,3528

CAD

Canadian dollar

1,4004

HKD

Hong Kong dollar

11,0946

NZD

New Zealand dollar

1,7662

SGD

Singapore dollar

1,7617

KRW

South Korean won

1 545,80

ZAR

South African rand

9,6628

CNY

Chinese yuan renminbi

9,2216

HRK

Croatian kuna

7,3850

IDR

Indonesian rupiah

12 267,45

MYR

Malaysian ringgit

4,3267

PHP

Philippine peso

62,193

RUB

Russian rouble

40,1025

THB

Thai baht

43,559

BRL

Brazilian real

2,2869

MXN

Mexican peso

16,9910

INR

Indian rupee

64,0680

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
**Exhibit      32.1**

| (1) | The                report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Dated:                            , 2008 | By:   | /s/                                    |
|------------------------------------------------------------------------------------------------------|-----------------|----------------------------------------|
|                                                                                                 |            |                                   |
|                                                                                                 |            | Wensheng                Chen      |
|                                                                                                 |            | Chief                Executive Officer |

----
<PAGE>   1

                                  EXHIBIT 21.1

                 LIST OF SUBSIDIARIES OF ATRIUM COMPANIES, INC.

         Atrium Door and Window Company of the Northeast, a Connecticut
corporation (the merged companies formerly named Vinyl Building Specialties of
Connecticut, Inc. and Bishop Manufacturing Company, Incorporated) (direct
subsidiary)

         Atrium Door and Window Company of New England, a Connecticut
corporation (formerly Bishop Manufacturing Company of New England, Inc.)
(indirect subsidiary)

         Atrium Door and Window Company of New York, a Connecticut corporation
(formerly Bishop Manufacturing Company of New York, Inc.) (direct subsidiary)

         Atrium Door and Window Company - West Coast, a Texas corporation
(formerly H-R Window Supply, Inc.) (direct subsidiary)
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Excel Global, Inc. (the "Company"), hereby
certifies, to such officer's knowledge, that the Company's Quarterly
Report on Form 10-Q for the quarter ended June 30, 2010 (the "Report")
fully complies with the requirements of Section 13(a) of the Securities
Exchange Act of 1934 and that the information contained in the Report
fairly presents, in all material respects, the financial condition and
results of operations of the Company.

                                 /s/ Betty Soumekh
                                 ----------------------
                                 Betty Soumekh
                                 Chief Executive Officer
                                 Chief Financial Officer

August 20, 2010
**Exhibit 10.23**

Description of Second Amendment to the Employment Agreement of Anthony L. Genito, effective as of August 28, 2009 

Effective as of August 28, 2009, the board of directors of Spectrum Brands, Inc. increased the annual base salary of Anthony L. Genito to $425,000, which increase amended that certain Amendment tothe Employment Agreement, effective as of February 24, 2009, by and between Spectrum Brands, Inc. and Anthony L. Genito. At that time, Mr. Genito’s target long term incentive plan payout amount was also increased to 150% of his basesalary.